Login / Signup

Author Correction: Targeting Toll-like receptor-driven systemic inflammation by engineering an innate structural fold into drugs.

Ganna PetrukManoj PuthiaFirdaus SamsudinJitka PetrlovaFranziska OlmMargareta MittendorferSnejana HyllénDag EdströmAnn-Charlotte StrömdahlCarl DiehlSimon EkströmBjörn WalseSven KjellströmPeter John BondSandra LindstedtArtur Schmidtchen
Published in: Nature communications (2023)
Keyphrases
  • toll like receptor
  • immune response
  • nuclear factor
  • inflammatory response
  • cancer therapy
  • drug induced